Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wellgistics Health (WGRX) Cash & Equivalents (2024 - 2025)

Wellgistics Health's Cash & Equivalents history spans 2 years, with the latest figure at $42571.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 95.86% year-over-year to $42571.0, compared with a TTM value of $42571.0 through Dec 2025, down 95.86%, and an annual FY2025 reading of $42571.0, down 95.86% over the prior year.
  • Cash & Equivalents for Q4 2025 was $42571.0 at Wellgistics Health, down from $4.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $4.2 million in Q3 2025, with the low at $42571.0 in Q4 2025.